Cargando…
Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280165/ https://www.ncbi.nlm.nih.gov/pubmed/37346302 http://dx.doi.org/10.3389/fphar.2023.1229673 |
| _version_ | 1785060744481472512 |
|---|---|
| author | Chandrasekaran, Balakumar Saravanan, Muthupandian |
| author_facet | Chandrasekaran, Balakumar Saravanan, Muthupandian |
| author_sort | Chandrasekaran, Balakumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10280165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102801652023-06-21 Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics Chandrasekaran, Balakumar Saravanan, Muthupandian Front Pharmacol Pharmacology Frontiers Media S.A. 2023-06-06 /pmc/articles/PMC10280165/ /pubmed/37346302 http://dx.doi.org/10.3389/fphar.2023.1229673 Text en Copyright © 2023 Chandrasekaran and Saravanan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Chandrasekaran, Balakumar Saravanan, Muthupandian Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title | Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title_full | Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title_fullStr | Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title_full_unstemmed | Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title_short | Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
| title_sort | editorial: pharmacological and biochemical perspectives of kinase inhibitors in cancer and covid-19 therapeutics |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280165/ https://www.ncbi.nlm.nih.gov/pubmed/37346302 http://dx.doi.org/10.3389/fphar.2023.1229673 |
| work_keys_str_mv | AT chandrasekaranbalakumar editorialpharmacologicalandbiochemicalperspectivesofkinaseinhibitorsincancerandcovid19therapeutics AT saravananmuthupandian editorialpharmacologicalandbiochemicalperspectivesofkinaseinhibitorsincancerandcovid19therapeutics |